Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia-Reference-Cited by-同舟云学术

Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia

Published:2002-12 Issue:3 Volume:3 Page:163-166
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Dimopoulos Meletios A.,Zervas Constantinos,Zomas Athanasios,Hamilos George,Gika Dimitra,Efstathiou Eleni,Panayiotidis Panayiotis,Vervessou Elina,Anagnostopoulos Nikolaos,Christakis John

Publisher

Elsevier BV

Subject

Cancer Research

Reference26 articles.

1. The spectrum of IgM monoclonal gammopathy in 430 cases;Kyle;Mayo Clin Proc,1987

2. Waldenstrom's macroglobulinemia;Dimopoulos;Blood,1994

3. Waldenstrom's macroglobulinemia: clinical features, complications, and management;Dimopoulos;J Clin Oncol,2000

4. Waldenstrom's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil;Kyle;Br J Haematol,2000

5. Prognostic factors and response to fludarabine therapy in patients with Waldenstrom macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003);Dhodapkar;Blood,2001

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-01

2. Waldenstrom Macroglobulinemia;Comprehensive Hematology and Stem Cell Research;2024

3. Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects;Annals of Hematology;2023-07-06

4. Should Patients with Waldenström Macroglobulinemia Receive a BTK Inhibitor as Frontline Therapy?;Hemato;2022-10-23

5. Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment;Cancer Medicine;2022-07-26